Research Tracker›Biomarker Atlas›Hepatitis C›AST

AST in Hepatitis C

AST is a hepatic marker reported as elevated in Hepatitis C when patients are compared with the reference group of the cited comparison (chronic HCV (CHC) patients vs healthy controls). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The finding is drawn from Al-Rawaf et al. 2024; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedHepatic

Summary

Direction in Hepatitis C↑ Elevated — higher than in the comparison group
CategoryHepatic
Compared againstchronic HCV (CHC) patients vs healthy controls
SourceAl-Rawaf et al. 2024 — doi:10.1186/s12860-024-00514-8
Condition atlasHepatitis C Biomarker Atlas

Other conditions where AST is reported

See the cross-condition hub: AST across conditions.

Related Hepatic markers in Hepatitis C

Full list: Hepatitis C Biomarker Atlas.

Frequently asked questions

Is AST high or low in Hepatitis C?

Elevated. Studies summarised in the OSMF atlas report higher AST in Hepatitis C than in the reference group of the cited comparison (chronic HCV (CHC) patients vs healthy controls). Source: Al-Rawaf et al. 2024.

Which test measures AST?

The atlas record does not list a standardised clinical test code (LOINC) for AST, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal AST result diagnostic of Hepatitis C?

No. No single biomarker is diagnostic of Hepatitis C. AST findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is AST specific to Hepatitis C?

No. The same marker is also reported in NAFLD / MASH (Metabolic-Associated Steatohepatitis) in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). AST in Hepatitis C: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/hepatitis-c/ast.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Page generated from hepatitis-c.json · Browse: Hepatitis C atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.